Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry

Archive ouverte

Jamee, Mahnaz | Azizi, Gholamreza | Baris, Safa | Karakoc-Aydiner, Elif | Ozen, Ahmet | Kiliç, Sara, Ş | Kose, Hulya | Chavoshzadeh, Zahra | Mahdaviani, Seyed, Alireza | Momen, Tooba | Shamsian, Bibi, Shahin | Fallahi, Mazdak | Sharafian, Samin | Gülez, Nesrin | Aygun, Ayşe | Karaca, Neslihan, Edeer | Kutukculer, Necil | Al Sukait, Nashat | Al Farsi, Tariq | Al-Tamemi, Salem | Khalifa, Nisreen | Shereen, Reda | El-Ghoneimy, Dalia | El-Owaidy, Rasha | Radwan, Nesrine | Alzyoud, Raed | Barbouche, Mohamed-Ridha | Ben-Mustapha, Imen | Mekki, Najla | Rais, Afef | Boukari, Rachida | Belbouab, Reda | Djenouhat, Kamel | Tahiat, Azzeddine | Touri, Souad | Elghazali, Gehad | Al-Hammadi, Suleiman | Shendi, Hiba, Mohammed | Alkuwaiti, Amna | Belaid, Brahim | Djidjik, Reda | Artac, Hasibe | Adeli, Mehdi | Sobh, Ali | Elnagdy, Marwa, H | Bahgat, Sara, A | Nasrullayeva, Gulnara | Chou, Janet | Rezaei, Nima | Al-Herz, Waleed | Geha, Raif, S | Abolhassani, Hassan | Rasouli, Seyed, Erfan | Esmaeili, Marzie | Yazdani, Reza | Delavari, Samaneh | Tavakol, Marzieh | Sadri, Homa | Karimi, Abdollah | Shiari, Reza | Alavi, Samin | Babaie, Delara | Eshghi, Peyman | Armin, Shahnaz | Vosughimotlagh, Ahmad | Eltan, Sevgi, Bilgic | Babayeva, Royala | Sefer, Asena, Pinar | Kolukisa, Burcu | Gungoren, Ezgi, Yalcin | Altunbas, Melek, Yorgun | Mammadova, Vafa

Edité par CCSD ; Elsevier -

International audience. Monogenic immune dysregulation diseases (MIDD) are caused by defective immunotolerance. This study was designed to increase knowledge on the prevalence and spectrum of MIDDs, genetic patterns, and outcomes in Middle East and North Africa (MENA). MIDD patients from 11 MENA countries (Iran, Turkey, Kuwait, Oman, Algeria, Egypt, United Arab Emirates, Tunisia, Jordan, Qatar, and Azerbaijan) were retrospectively evaluated. 343 MIDD patients (58% males and 42% female) at a median (IQR) age of 101 (42–192) months were enrolled. The most common defective genes were LRBA (23.9%), LYST (8.2%), and RAB27A (7.9%). The most prevalent initial and overall manifestations were infections (32.2% and 75.1%), autoimmunity (18.6% and 41%), and organomegaly (13.3% and 53.8%), respectively. Treatments included immunoglobulin replacement therapy (53%), hematopoietic stem cell transplantation (HSCT) (14.3%), immunosuppressives (36.7%), and surgery (3.5%). Twenty-nine (59.2%) patients survived HSCT. Along with infectious complications, autoimmunity and organomegaly may be the initial or predominant manifestations of MIDD.

Suggestions

Du même auteur

The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity

Archive ouverte | Baris, Safa | CCSD

International audience. Human inborn errors of immunity (IEI) are a group of 485 distinct genetic disorders affecting children and adults. Signs and symptoms of IEI are heterogeneous, and accurate diagnosis can be c...

Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency

Archive ouverte | Ghosh, Sujal | CCSD

International audience. Biallelic mutations in the genes encoding CD27 or its ligand CD70 underlie inborn errors of immunity characterized predominantly by EBVassociated immune dysregulation, such as chronic viremia...

New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.

Archive ouverte | Shaghaghi, Mohammadreza | CCSD

International audience. Widespread administration of oral poliovirus vaccine (OPV) has decreased global incidence of poliomyelitis by ≈99.9%. However, the emergence of vaccine-derived polioviruses (VDPVs) is threate...

Chargement des enrichissements...